GI Innovation, Inc. (358570.KQ)
KRW 9790.0
(-4.39%)
KRW 9790.0
(-4.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -55.6 Billion KRW | 20.97% |
| 2022 | -70.35 Billion KRW | -118.41% |
| 2021 | -32.21 Billion KRW | -40.6% |
| 2020 | -22.9 Billion KRW | -44.94% |
| 2019 | -15.8 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -9.58 Billion KRW | 25.45% |
| 2024 Q1 | -12.85 Billion KRW | -41.69% |
| 2023 Q4 | -9.07 Billion KRW | 26.45% |
| 2023 Q3 | -12.33 Billion KRW | 41.27% |
| 2023 FY | -55.6 Billion KRW | 20.97% |
| 2023 Q2 | -21 Billion KRW | -59.09% |
| 2023 Q1 | -13.2 Billion KRW | 42.8% |
| 2022 Q2 | -17.65 Billion KRW | -39.94% |
| 2022 FY | -70.35 Billion KRW | -118.41% |
| 2022 Q4 | -23.07 Billion KRW | -35.68% |
| 2022 Q3 | -17 Billion KRW | 3.65% |
| 2022 Q1 | -12.61 Billion KRW | -18.28% |
| 2021 FY | -32.21 Billion KRW | -40.6% |
| 2021 Q4 | -10.66 Billion KRW | -129.81% |
| 2021 Q3 | -4.64 Billion KRW | 0.0% |
| 2020 FY | -22.9 Billion KRW | -44.94% |
| 2019 FY | -15.8 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 55.526% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | -1592.674% |
| BINEX Co., Ltd. | 1.04 Billion KRW | 5434.895% |
| Bioneer Corporation | 791.75 Million KRW | 7122.855% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | -995.888% |
| MEDIPOST Co., Ltd. | -25.13 Billion KRW | -121.258% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | -79.872% |
| Helixmith Co., Ltd | -35.24 Billion KRW | -57.761% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | -489.947% |
| Medy-Tox Inc. | 17.32 Billion KRW | 420.994% |
| Peptron, Inc. | -15.6 Billion KRW | -256.367% |
| Amicogen, Inc. | 2.05 Billion KRW | 2804.272% |
| Genexine, Inc. | -41.24 Billion KRW | -34.827% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | -539.103% |
| LegoChem Biosciences, Inc. | -80.82 Billion KRW | 31.203% |
| ALTEOGEN Inc. | -9.73 Billion KRW | -471.065% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 155.153% |
| SillaJen, Inc. | -21.34 Billion KRW | -160.489% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | 2211.286% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | -205.761% |
| Genomictree Inc. | -17.3 Billion KRW | -221.344% |
| MedPacto, Inc. | -28.75 Billion KRW | -93.39% |
| D&D Pharmatech | -13.48 Billion KRW | -312.299% |
| EASY BIO,Inc. | 20.63 Billion KRW | 369.512% |